Biology Reference
In-Depth Information
Farzan M, et al. 1997. Two orphan seven-transmembrane segment receptors which are expressed in
CD4-positive cells support simian immunode®ciency virus infection. J Exp Med 186: 405±411.
Haugland RP. 1996. Handbook of Fluorescent Probes and research Chemicals, 6th Edition.
Eugene, OR, Molecular Probes.
He J, et al. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:
645±649.
Hladik F, et al. 1999. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: im-
plications for the ontogeny of the CCR5
Th1 phenotype. J Immunol 163: 2306±2313.
Horuk R, et al. 1998. The CC chemokine I309 is a functional ligand for ChemR1/CCR8 and in-
hibits ChemR1/CCR8 dependent infection by diverse HIV-1 strains. J Biol Chem 273: 386±391.
Husman AMD, Schuitemaker H. 1998. Chemokine receptors and the clinical course of HIV-1 in-
fection. Trends Microbiol 6: 457±470.
John GC, et al. 2000. Maternal SDF1 3
0
A polymorphism is associated with increased perinatal
human immunode®ciency virus type 1 transmission. J Virol 74: 5736±5739.
Kabat D, et al. 1994. Di¨erences in CD4 dependence for infectivity of laboratory-adapted and pri-
mary patient isolates of human immunode®ciency virus type 1. J Virol 68: 2570±2577.
Katzenstein TL, et al. 1997. HIV-infected individuals with the CCR delta32/CCR5 genotype have
lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do
patients with the wild type. Copenhagen AIDS Cohort Study Group. J Acquir Immune De®c
Syndr Hum Retrovirol 16: 10±14.
Kozak SL, et al. 1997. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient
and laboratory-adapted isolates of human immunode®ciency virus type 1. J Virol 71: 873±882.
Kuhmann SE, et al. 2000. Cooperation of multiple CCR5 coreceptors is required for infections by
human immunode®ciency virus type I. J Virol 74: 7005±7015.
Kuss I, et al. 1999. Clinical signi®cance of decreased zeta chain expression in peripheral blood
lymphocytes of patients with head and enck cnacers. Clin Cancer Res 5: 329±334.
Lavabre-Bertrand T. 1996. Flow cytometric quantitation in chronic leukemias. Eur J Histochem 1:
33±38.
Lee B, Montaner LJ. 1999. Chemokine immunobiology in HIV-1 pathogenesis. J Leuk Biol 65:
552±565.
Lee B, et al. 1999a. Epitope mapping of CCR5 reveals multiple conformational states and distinct
but overlapping structures involved in chemokine and coreceptor function. J Biol Chem 274:
9617±9626.
Lee B, et al. 1999b. Quanti®cation of CD4, CCR5, and CXCR4 levels on lymphocyte subsets,
dendritic cells, and di¨erentially conditioned monocyte-derived macrophages. Proc Natl Acad
Sci USA 96: 5215±5220.
Liao F, et al. 1997. STRL33, A novel chemokine receptor-like protein, functions as a fusion co-
factor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 185: 2015±2023.
Liu Z, et al. 1996. Elevated relative ¯uorescence intensity of CD38 antigen expression on CD8
T
cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up Cytometry
26: 1±7.
Majka M, et al. 1999. Bone marrow CD34 cells and megakaryoblasts secrete beta-chemokines
that block infection of hematopoietic cells by M-tropic R5 HIV. J Clin Invest 104: 1739±1749.
McKnight A, et al. 1998. A broad range of chemokine receptors are used by primary isolates of
human immunode®ciency virus type 2 as coreceptors with CD4. J Virol 72: 4065±4071.
Mo H, et al. 1998. Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4
T cells and monocytes from cord and adult blood. AIDS Res Hum Retroviruses 14: 607±617.
Moore JP. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276: 51±
52.
